By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Isis Pharmaceuticals, Inc. 

Carlsbad Research Center
2292 Faraday Avenue
Carlsbad  California  92008-7208  U.S.A.
Phone: 760-931-9200 Fax: 760-603-4650



Company News
Webcast Alert: Isis Pharma (ISIS)' Second Quarter 2015 Financial Results Conference Call 7/28/2015 12:48:43 PM
Isis Pharma (ISIS) Reports Data From ISIS-TTR Rx In Patients With Transthyretin Amyloid-Related Cardiomyopathy 7/27/2015 10:09:15 AM
Isis Pharma (ISIS) Release: Positive Clinical Data From Lp(a) Lowering Drug ISIS-APO(a) Rx Published In The Lancet 7/23/2015 8:48:29 AM
Isis Pharma (ISIS) Initiates Clinical Study Of ISIS-HTT Rx In Patients With Huntington's Disease 7/21/2015 7:54:17 AM
Isis Pharma (ISIS) Earns $2.15M For Advancing ISIS-SMN Rx In Children With Spinal Muscular Atrophy 7/14/2015 7:06:36 AM
Webcast Alert: Corporate Presentation At The 2015 Isis Pharma (ISIS) Annual Stockholder Meeting 6/30/2015 8:02:48 AM
Isis Pharma (ISIS) Promoted To The Large-Cap Russell 1000 Index 6/30/2015 7:47:15 AM
Isis Pharma (ISIS) Reports Data From ISIS-SMN Rx In Children With Spinal Muscular Atrophy 6/22/2015 7:35:51 AM
Isis Pharma (ISIS) To Present A General Corporate Update At Its 2015 Annual Meeting Of Stockholders And Open House 6/16/2015 10:47:38 AM
Isis Pharma (ISIS) To Host Webcast To Discuss Data From ISIS-SMN Rx Phase 2 Study In Infants With Spinal Muscular Atrophy 6/11/2015 7:42:01 AM